Monoclonal antibody-ricin-chain-A conjugate

Drug Profile

Monoclonal antibody-ricin-chain-A conjugate

Alternative Names: Monoclonal antibody immunotoxin; RAC 907; RFB4 ricin A; RFT5 dgA

Latest Information Update: 29 Jun 1999

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator XOMA
  • Class Immunotoxins; Monoclonal antibodies
  • Mechanism of Action Immunosuppressants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Hodgkin's disease; Transplant rejection

Most Recent Events

  • 29 Jun 1999 Discontinued-II for Hodgkin's disease in Germany (IV-infusion)
  • 29 Jun 1999 Discontinued-Preclinical for Transplant rejection in USA (Unknown route)
  • 07 Apr 1999 Merger of Astra and Zeneca to form AstraZeneca completed
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top